DOSELET
Live / Allowed — Notice of allowance issued (as of 01 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99645261
- Mark type
- Word mark
- Filed
- 10 Feb 2026
- Published for opposition
- 07 Jul 2026
- Attorney of record
- Michael R. Graif
Goods and services
- Class 001 — Chemicals: Delivery platforms for nutraceuticals, namely bioactive encapsulated nanofiber products for use in food, cosmetics, and supplements
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight reduction and long term weight loss maintenance; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of bioactive encapsulated nanofiber products that facilitate the delivery of pharmaceutical preparations
- Class 042 — Scientific and technological services: Scientific research and development services for customization of delivery platforms for nutraceuticals, namely bioactive encapsulated nanofiber products for others
Owner
- Nexture Bio, Inc., Xenia, OH, US
- Nexture Bio, Inc., Xenia, OH, US
Prosecution history
- 01 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jun 2026 — ASSIGNED TO EXAMINER
- 09 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Feb 2026 — NEW APPLICATION ENTERED